Salivary concentrations of secretory leukocyte protease inhibitor and matrix metallopeptidase-9 following a single bout of exercise are associated with intensity and hydration status.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 14 06 2022
accepted: 25 08 2023
medline: 24 11 2023
pubmed: 22 11 2023
entrez: 22 11 2023
Statut: epublish

Résumé

To investigate the effects of exercise on salivary concentrations of inflammatory markers by analyzing a panel of 25 inflammatory markers in subjects who had participated in bicycle ergometer tests varying in workload and hydration status. Fifteen healthy young men (20-35 years) had performed 4 different exercise protocols of 1 hour duration in a randomly assigned cross-over design, preceded by a rest protocol. Individual workloads depended on participant's pre-assessed individual maximum workload (Wmax): rest (protocol 1), 70% Wmax in hydrated (protocol 2) and dehydrated (protocol 3) state, 50% Wmax (protocol 4) and intermittent 85%/55% Wmax in 2 min blocks (protocol 5). Saliva samples were collected before (T0) and immediately after exercise (T1), and at several time points after exercise (2 hours (T3), 3 hours (T4), 6 hours (T5) and 24 hours (T6)). Secretory Leukocyte Protease Inhibitor (SLPI), Matrix Metallopeptidase-9 (MMP-9) and lactoferrin was analyzed using a commercial ELISA kit, a panel of 22 cytokines and chemokines were analyzed using a commercial multiplex immunoassay. Data was analyzed using a multilevel mixed linear model, with multiple test correction. Among a panel of 25 inflammatory markers, SLPI concentrations were significantly elevated immediately after exercise in all protocols compared to rest and higher concentrations reflected the intensity of exercise and hydration status. MMP-9 showed a significant increase in the 70% Wmax dehydrated, 50% Wmax and intermittent protocols. Salivary concentrations of SLPI and MMP-9 seem associated with exercise intensity and hydration status and may offer non-invasive biomarkers to study (local) inflammatory responses to different exercise intensities in human studies.

Identifiants

pubmed: 37992002
doi: 10.1371/journal.pone.0291297
pii: PONE-D-22-17078
pmc: PMC10664895
doi:

Substances chimiques

Secretory Leukocyte Peptidase Inhibitor 0
Matrix Metalloproteinase 9 EC 3.4.24.35

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0291297

Informations de copyright

Copyright: © 2023 Knipping et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

Karen Knipping, Nicole Buurman and Johan Garssen are employee of Danone Nutricia Research. All other authors declare no conflict of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Biochim Biophys Acta. 2009 Apr;1788(4):864-71
pubmed: 18952050
J Muscle Res Cell Motil. 2017 Apr;38(2):231-239
pubmed: 28667428
J Strength Cond Res. 2011 Nov;25(11):2944-54
pubmed: 22024610
Appl Physiol Nutr Metab. 2012 Oct;37(5):850-9
pubmed: 22686429
Eur J Clin Nutr. 2018 Jan;72(1):69-76
pubmed: 28853743
Exerc Immunol Rev. 2020;26:8-22
pubmed: 32139352
Vasc Health Risk Manag. 2016 Jul 14;12:287-95
pubmed: 27471391
Med Sci Sports Exerc. 2015 Jul;47(7):1390-8
pubmed: 25380472
Medicine (Baltimore). 2017 Sep;96(37):e8072
pubmed: 28906407
J Appl Physiol (1985). 1997 May;82(5):1385-94
pubmed: 9134882
Intest Res. 2015 Jan;13(1):11-8
pubmed: 25691839
Exp Physiol. 2017 Jan 1;102(1):86-99
pubmed: 27808433
BMC Microbiol. 2012 Jun 13;12:105
pubmed: 22694805
Clin Nutr. 2019 Oct;38(5):2251-2258
pubmed: 30340895
Brain Behav Immun. 2020 Aug;88:887-900
pubmed: 32371089
Infect Immun. 2005 Mar;73(3):1271-4
pubmed: 15731023
Crit Rev Biochem Mol Biol. 2013 May-Jun;48(3):222-72
pubmed: 23547785
Eur J Appl Physiol. 2017 May;117(5):1047-1051
pubmed: 28341903
Front Physiol. 2020 Sep 04;11:1006
pubmed: 33013439
Am J Physiol Gastrointest Liver Physiol. 2015 Dec 15;309(12):G988-97
pubmed: 26514773
J Clin Immunol. 1985 Sep;5(5):321-8
pubmed: 3932453
Eur J Appl Physiol. 2012 Sep;112(9):3227-37
pubmed: 22230919
Physiol Rep. 2016 Oct;4(20):
pubmed: 27798350
Brain Behav Immun. 2015 Feb;44:253-69
pubmed: 25205395
Eur J Appl Physiol. 2008 Jul;103(4):477-9
pubmed: 18351377
Med Sport Sci. 2012;59:47-56
pubmed: 23075554
Crit Rev Biochem Mol Biol. 2002 Dec;37(6):375-536
pubmed: 12540195
Sports Med Open. 2016 Dec;2(1):21
pubmed: 27747777
Scand J Med Sci Sports. 2012 Jun;22(3):410-7
pubmed: 21385218
J Appl Physiol (1985). 2016 Mar 15;120(6):692-701
pubmed: 26359485
Physiology (Bethesda). 2013 Nov;28(6):391-403
pubmed: 24186934
Eur J Appl Physiol. 2009 May;106(2):277-84
pubmed: 19263072
Cytokine. 2019 Jul;119:57-61
pubmed: 30884427
J Appl Physiol (1985). 2007 Aug;103(2):693-9
pubmed: 17303714
Front Physiol. 2020 Jan 09;10:1550
pubmed: 31992987
J Int Soc Sports Nutr. 2020 Oct 30;17(1):52
pubmed: 33126891
Int J Oral Sci. 2016 Sep 29;8(3):133-7
pubmed: 27585820
Br J Sports Med. 2014 Jun;48(12):980-6
pubmed: 23134759
Sports Med. 2003;33(11):853-67
pubmed: 12959623
Nat Rev Immunol. 2004 Aug;4(8):617-29
pubmed: 15286728
Eur J Appl Physiol. 2017 May;117(5):931-941
pubmed: 28290057
J Leukoc Biol. 2007 Dec;82(6):1375-81
pubmed: 17709402
Brain Behav Immun. 2013 Nov;34:164-75
pubmed: 23999491
Br J Sports Med. 2000 Aug;34(4):246-51
pubmed: 10953894
Eur J Appl Physiol. 2013 May;113(5):1249-55
pubmed: 23160657
Biochem Soc Trans. 2002 Apr;30(2):111-5
pubmed: 12023836
Eur J Appl Physiol. 2015 Sep;115(9):1887-95
pubmed: 25893563
Infect Immun. 1998 Jun;66(6):2447-52
pubmed: 9596701
Eur J Appl Physiol. 2005 Mar;93(5-6):679-86
pubmed: 15778897
Curr Pharm Des. 2016;22(24):3730-48
pubmed: 27000826
Front Immunol. 2018 Apr 16;9:648
pubmed: 29713319
Am J Clin Nutr. 2010 Sep;92(3):565-73
pubmed: 20631205
J Can Dent Assoc. 2002 Mar;68(3):170-4
pubmed: 11911813
Med Sci Sports Exerc. 2007 Feb;39(2):377-90
pubmed: 17277604
Arch Oral Biol. 2011 Apr;56(4):401-11
pubmed: 21094936
PLoS One. 2019 Feb 6;14(2):e0207166
pubmed: 30726210
Crit Rev Oral Biol Med. 2002;13(2):197-212
pubmed: 12097361
J Cell Biochem. 2012 Apr;113(4):1159-69
pubmed: 22275073
Physiol Rev. 2000 Jul;80(3):1055-81
pubmed: 10893431
Nat Rev Immunol. 2011 Aug 05;11(9):607-15
pubmed: 21818123
J Clin Med. 2021 Feb 01;10(3):
pubmed: 33535653
Exerc Immunol Rev. 2022;28:36-52
pubmed: 35452397
Cell. 1997 Feb 7;88(3):417-26
pubmed: 9039268

Auteurs

Karen Knipping (K)

Danone Nutricia Research, Utrecht, The Netherlands.
Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

Shirley W Kartaram (SW)

Research Group Innovative Testing in Life Sciences and Chemistry, University of Applied Sciences Utrecht, Utrecht, The Netherlands.

Marc Teunis (M)

Research Group Innovative Testing in Life Sciences and Chemistry, University of Applied Sciences Utrecht, Utrecht, The Netherlands.

Nicolaas P A Zuithoff (NPA)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Nicole Buurman (N)

Danone Nutricia Research, Utrecht, The Netherlands.

Laura M'Rabet (L)

Research Group Innovative Testing in Life Sciences and Chemistry, University of Applied Sciences Utrecht, Utrecht, The Netherlands.

Klaske van Norren (K)

Nutritional Biology, Division Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands.

Renger Witkamp (R)

Nutritional Biology, Division Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands.

Raymond Pieters (R)

Research Group Innovative Testing in Life Sciences and Chemistry, University of Applied Sciences Utrecht, Utrecht, The Netherlands.
Institute for Risk Assessment Sciences, Immunotoxicology (IRAS), Utrecht University, Utrecht, The Netherlands.

Johan Garssen (J)

Danone Nutricia Research, Utrecht, The Netherlands.
Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH